IgG4-related disease can involve almost any organ and often begins without symptoms. The panel defines the condition, outlines who it affects, and describes the many ways it presents.
Back
IgG4-Related Disease: Navigating Diagnosis and the Expanding B-Cell-Targeted Treatment Landscape
International experts in gastroenterology, hepatology, rheumatology, and immunology discuss how IgG4-related disease presents across organ systems, how to distinguish it from its mimics, and why B cells drive its biology. They review glucocorticoid-sparing strategies, phase 3 data on B-cell depletion and inhibition, emerging therapies, long-term monitoring, and new international guidelines.
IgG4-Related Disease: Navigating Diagnosis and the Expanding B-Cell-Targeted Treatment Landscape
Episodes
All
All
Malignancy, vasculitis, and sarcoidosis all overlap with IgG4-related disease. The panel reviews key mimics by organ and contrasts manifestations needing immediate treatment with those suited to active surveillance.
Advertisement
Advertisement
Trending on HCPLive
1
Tozorakimab Improves Daily Respiratory Symptoms in COPD: OBERON, TITANIA
2
Tozorakimab Sustains COPD Exacerbation Benefit to 2 Years: Henrik Watz, MD
3
Frespaciguat Misses 6MWD End Point in PH-COPD: Gabor Kovacs, MD, PhD
4
AAD's New HS Guidelines Flag 'Step Therapy' as Top Barrier to Care
5